A detailed history of Range Financial Group LLC transactions in Amgen Inc stock. As of the latest transaction made, Range Financial Group LLC holds 8,164 shares of AMGN stock, worth $2.55 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares
8,164
Previous 7,857 3.91%
Holding current value
$2.55 Million
Previous $2.26 Million 2.61%
% of portfolio
1.21%
Previous 1.38%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

BUY
$268.87 - $324.56 $82,543 - $99,639
307 Added 3.91%
8,164 $2.32 Million
Q4 2023

Jan 10, 2024

BUY
$255.7 - $288.46 $131,941 - $148,845
516 Added 7.03%
7,857 $2.26 Million
Q3 2023

Oct 10, 2023

SELL
$218.65 - $271.46 $25,800 - $32,032
-118 Reduced 1.58%
7,341 $1.97 Million
Q2 2023

Jul 18, 2023

BUY
$214.27 - $253.37 $29,783 - $35,218
139 Added 1.9%
7,459 $1.66 Million
Q1 2023

Apr 03, 2023

BUY
$225.79 - $275.2 $35,223 - $42,931
156 Added 2.18%
7,320 $1.77 Million
Q4 2022

Jan 13, 2023

BUY
$229.03 - $291.01 $42,828 - $54,418
187 Added 2.68%
7,164 $0
Q3 2022

Oct 13, 2022

SELL
$224.46 - $253.15 $234,111 - $264,035
-1,043 Reduced 13.0%
6,977 $1.57 Million
Q2 2022

Jul 11, 2022

BUY
$230.71 - $256.74 $22,148 - $24,647
96 Added 1.21%
8,020 $1.95 Million
Q1 2022

May 18, 2022

BUY
$219.27 - $242.57 $49,116 - $54,335
224 Added 2.91%
7,924 $1.92 Million
Q4 2021

Jul 11, 2022

BUY
$198.88 - $227.6 $53,498 - $61,224
269 Added 3.62%
7,700 $1.73 Million
Q3 2021

Jul 11, 2022

BUY
$212.27 - $248.7 $58,161 - $68,143
274 Added 3.83%
7,431 $1.58 Million
Q2 2021

Jul 11, 2022

BUY
$233.58 - $259.14 $203,448 - $225,710
871 Added 13.86%
7,157 $1.75 Million
Q1 2021

Jul 11, 2022

BUY
$221.91 - $258.6 $1.39 Million - $1.63 Million
6,286 New
6,286 $1.56 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $167B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Range Financial Group LLC Portfolio

Follow Range Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Range Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Range Financial Group LLC with notifications on news.